Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients

被引:0
|
作者
Gao, Xiang [1 ]
Jin, Xiaowei [1 ]
Huang, Rui [1 ]
Li, Zhenxing [1 ]
Zhang, Hanle [2 ]
Fan, Pei [1 ]
机构
[1] Wenzhou Med Univ, Yuying Childrens Hosp, Dept Orthoped, Affiliated Hosp 2, 109 Xueyuan West Rd, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Affiliated Hosp 2, Dept Rehabil, Wenzhou, Zhejiang, Peoples R China
关键词
Deep vein Thromboembolism; Nadroparin; Fondaparinux Sodium; Total hip arthroplasty; Total knee arthroplasty; VENOUS THROMBOEMBOLISM; ENOXAPARIN; PROPHYLAXIS; THROMBOSIS; SURGERY;
D O I
10.1186/s12893-024-02440-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives To compare the efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism (DVT) in lower extremities after total hip arthroplasty (THA) and total knee arthroplasty (TKA). Methods A total of 592 patients were enrolled in the study. Clinical data of patients who underwent total hip arthroplasty (THA) and total knee arthroplasty (TKA) in our hospital from December 2021 to September 2022 were retrospectively collected, which mainly included patients' general information, surgery-related information, and DVT-related information. The patients were categorized into the nadroparin group(n = 278) and the fondaparinux sodium group(n = 314) according to the types of anticoagulants used. Anticoagulant therapy began 12-24 h after operation and continued until discharge. DVT prevalence between two groups was compared. The Statistical Package for Social Sciences (SPSS) software version 25 (SPSS, Armonk, NY, USA) was used for statistical analysis. Results The prevalence of DVT in the nadroparin group and the fondaparinux sodium group was 8.3% (23/278) and 15.0% (47/314), respectively(p = 0.012). Statistical analysis showed that nadroparin group showed a lower prevalence of thrombosis than fondaparinux group (OR = 1.952, P = 0.012). Subgroup analyses showed that nadroparin group had a lower prevalence of DVT than fondaparinux group in some special patients groups such as female patients (OR = 2.258, P = 0.007), patients who are 65-79 years old (OR = 2.796, P = 0.004), patients with hypertension (OR = 2.237, P = 0.042), patients who underwent TKA (OR = 2.091, P = 0.011), and patients who underwent combined spinal-epidural anesthesia (OR = 2.490, P = 0.003) (P < 0.05). Conclusion Nadroparin may have an advantage over fondaparinux sodium in preventing DVT in lower extremities after THA and TKA.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin
    Ricket, Abby L.
    Stewart, David W.
    Wood, Robert C.
    Cornett, Lyndsey
    Odle, Brian
    Cluck, David
    Freshour, Jessica
    El-Bazouni, Hadi
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (04) : 270 - 275
  • [22] Clinical experience with fondaparinux in antiaggregate patients undergoing total hip and knee arthroplasty
    Grappiolo, Guido
    Scardino, Marco
    Mazziotta, Giuseppe
    Quaini, Stefano
    Lodigiani, Corrado
    Ferrari, Matteo Carlo
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 (03) : 179 - 182
  • [23] Prevention of VTE Following Total Hip and Knee Arthroplasty in Hemophilia Patients
    Stein, Matthew I.
    Park, Justin
    Raterman, Stephen
    ORTHOPEDICS, 2011, 34 (05) : 389 - 392
  • [24] Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
    Friedman, Richard J.
    Gallus, Alexander S.
    Cushner, Fred D.
    FitzGerald, Gordon
    Anderson, Frederick A., Jr.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 87 - 97
  • [25] Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis
    Jie Zhang
    Zhihao Chen
    Jilin Zheng
    Steffen J Breusch
    Jing Tian
    Archives of Orthopaedic and Trauma Surgery, 2015, 135 : 759 - 772
  • [26] Patient compliance with deep vein thrombosis prophylaxis after total hip and total knee arthroplasty
    Wiznia, Daniel H.
    Swami, Nishwant
    Nguyen, Jenny
    Musonza, Eric
    Lynch, Chris
    Gibson, David
    Pelker, Richard
    HEMATOLOGY REPORTS, 2019, 11 (02) : 30 - 33
  • [27] Deep vein thrombosis after total knee arthroplasty
    Wang, CJ
    Wang, JW
    Chen, LM
    Chen, HS
    Yang, BY
    Cheng, SM
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (11) : 848 - 853
  • [29] Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty
    Yamaguchi, Toshio
    Hasegawa, Masahiro
    Niimi, Rui
    Sudo, Akihiro
    THROMBOSIS RESEARCH, 2010, 126 (04) : E323 - E326
  • [30] Efficacy and Safety Study of Low-Molecular- Weight Heparin and Fondaparinux Sodium After Hip Arthroplasty: A Retrospective Cohort Study
    Haibier, Abuduwupuer
    Yusufu, Alimujiang
    Lin, Hang
    Kayierhan, Aiben
    Abudukelimu, Yimuran
    Abudurexiti, Tuerhongjiang
    ORTHOPEDIC RESEARCH AND REVIEWS, 2023, 15 : 253 - 261